Morgan Stanley’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.77M | Buy |
|
|||||
|
2024
Q3 | $291K | Sell |
|
|||||
|
2024
Q2 | $210K | Sell |
|
|||||
|
2024
Q1 | $3.69M | Sell |
|
|||||
|
2023
Q4 | $12.7M | Buy |
|
|||||
|
2023
Q3 | $380K | Sell |
|
|||||
|
2023
Q2 | $1.07M | Sell |
|
|||||
|
2023
Q1 | $841K | Buy |
|
|||||
|
2022
Q4 | $403K | Buy |
|
|||||
|
2022
Q3 | $227K | Sell |
|
|||||
|
2022
Q2 | $511K | Buy |
|
|||||
|
2022
Q1 | $207K | Sell |
|
|||||
|
2021
Q4 | $453K | Buy |
|
|||||
|
2021
Q3 | $263K | Sell |
|
|||||
|
2021
Q2 | $1.51M | Buy |
|
|||||
|
2021
Q1 | $1.06M | Buy |
|
|||||
|
2020
Q4 | $417K | Buy |
|
|||||
|
2020
Q3 | $206K | Buy |
|
|||||
|
2020
Q2 | $70K | Buy |
|
|||||
|
2020
Q1 | $28K | Sell |
|
|||||
|
2019
Q4 | $151K | Buy |
|
|||||
|
2019
Q3 | $27K | Sell |
|
|||||
|
2019
Q2 | $780K | Buy |
|
|||||
|
2019
Q1 | $44K | Sell |
|
|||||
|
2018
Q4 | $161K | Sell |
|
|||||
|
2018
Q3 | $591K | Sell |
|
|||||
|
2018
Q2 | $650K | Buy |
|
|||||
|
2018
Q1 | $49K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $2K | Sell |
|
|||||
|
2017
Q2 | $1K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $11K | Buy |
|
|||||
|
2016
Q3 | $2K | Sell |
|
|||||
|
2016
Q2 | $1K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2K | Sell |
|
|||||
|
2015
Q3 | $569K | Buy |
|
|||||
|
2015
Q2 | $192K | Sell |
|
|||||
|
2015
Q1 | $299K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $10K | Buy |
|